<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22813" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>A Review of Hereditary Colorectal Cancers</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Medina Pab&#x000f3;n</surname>
            <given-names>Miguel A.</given-names>
          </name>
          <aff>University Industrial Santander / University CES</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Babiker</surname>
            <given-names>Hani M.</given-names>
          </name>
          <aff>University of Arizona Cancer Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Miguel Medina Pab&#x000f3;n declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hani Babiker declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22813.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Colorectal cancer is the fourth leading cause of death in the world. Many cases of colorectal cancer are associated with lifestyle factors such as obesity and lack of exercise, inadequate consumption of fruits, vegetables, fiber, fish, vitamin C, dairy products, and vitamin D, and excessive consumption of alcohol and red meat. The inherited colorectal cancer syndromes are a series of diseases in which specific mutations predispose to colorectal cancer. They are more aggressive and have a worse prognosis since they generally form additional tumors and do not always respond to chemotherapy. This activity will review the most common genetic syndromes associated with colorectal cancer and outline the medical and surgical treatment approach according to current evidence. This activity will highlight the role of the interprofessional team in recognizing and treating colorectal cancer.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain how to counsel a patient about lifestyle to decrease their risk of developing sporadic colorectal cancer.</p></list-item><list-item><p>Identify the types of hereditary colorectal cancer toward which the Modified Betheseda Criteria and the Amsterdam II Criteria are geared.</p></list-item><list-item><p>Describe a patient presentation consistent with hereditary polyposis colorectal cancer.</p></list-item><list-item><p>Outline approaches that the interprofessional care team can use to assist in recognizing, preventing, and managing colorectal cancer.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22813&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22813">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22813.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Colorectal cancer (CRC) is the world's fourth leading cause of death. It has links with inappropriate food habits such as low consumption of fruits, vegetables, fiber, fish, vitamin C, dairy products, and vitamin D, and high consumption of foods containing heme-iron (red and processed meat). Moreover, other factors that increase its incidence include poor lifestyles such as high alcohol consumption, obesity, and lack of exercise. The inherited CRC syndromes are a series of diseases that have specific mutations that predispose to CRC. These are more aggressive and have a worse prognosis since they correlate with other tumors, and some do not respond to chemotherapy.&#x000a0;</p>
        <p>Early diagnosis is challenging for physicians due to the absence of pathognomonic clinical findings. The evidence shows that 50% of the patients are asymptomatic and usually present with symptoms (such as rectal bleeding, weight loss, and intestinal obstruction) when the disease is already advanced.&#x000a0;Familial adenomatous polyposis (FAP) and syndromes not associated with polyposis, such as Lynch syndrome, are the most common cause of the onset of hereditary syndromes.&#x000a0;When considered together, they represent 6% to 10% of all cases of CRC.<xref ref-type="bibr" rid="article-22813.r1">[1]</xref></p>
        <p>Estimates are that tumors found in young adults are related to hereditary CRC syndromes. This article will review the most common genetic syndromes in the development of CRC and the medical-surgical treatment approach according to current evidence.</p>
      </sec>
      <sec id="article-22813.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Hereditary colorectal cancer (HCRC) is not a single disease; it is a group of diseases or syndromes with a mutational genetic component; these generate a clinically differentiated phenotype. It subdivides into two large HNPCC groups and the HPCC:</p>
        <p><bold>Hereditary non-polyposis colorectal cancer (HNPCC)</bold> is an autosomal dominant cancer syndrome; the incidence of this syndrome is&#x000a0;1.7 to 4.2% among all CRCs patients (represents 3 to 8 cases per million inhabitants in the world, according to Globocan 2018).<xref ref-type="bibr" rid="article-22813.r2">[2]</xref><xref ref-type="bibr" rid="article-22813.r3">[3]</xref><xref ref-type="bibr" rid="article-22813.r4">[4]</xref><xref ref-type="bibr" rid="article-22813.r3">[3]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Lynch syndrome (LS) is the commonest of hereditary cancers and correlates with an increased risk of colorectal, endometrium, ovary, stomach, and small bowel cancer.&#x000a0;LS has associations with mutations of DNA mismatch repair&#x000a0;(MMR)as MLH1(76%), MSH2(40%), MSH6, PMS2, and EPCAM.<xref ref-type="bibr" rid="article-22813.r5">[5]</xref> LS is incidence represents 3 to 5 cases per million inhabitants, according to Globocan 2018).<xref ref-type="bibr" rid="article-22813.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Sporadic colorectal carcinomas, MLH1-/PMS2-deficient.<xref ref-type="bibr" rid="article-22813.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Muir-Torre syndrome:(&#x000a0;The genes most commonly mutated MLH1, MSH2, MSH6, and PMS2). Its incidence represents 2 cases per ten million inhabitants, according to Globocan 2018).<xref ref-type="bibr" rid="article-22813.r8">[8]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Turcot syndrome type I: The frequency is approximately 20% to 25% among all TS. It is related to mutations of the MMR gene.<xref ref-type="bibr" rid="article-22813.r9">[9]</xref></p>
          </list-item>
        </list>
        <p><bold>Hereditary polyposis colorectal cancer (HPCC)&#x000a0;</bold>accounts for approximately 3 to 5 % of all CRC cases.<xref ref-type="bibr" rid="article-22813.r10">[10]</xref><xref ref-type="bibr" rid="article-22813.r11">[11]</xref>&#x000a0;(represents 5 to 9 cases per million inhabitants globally, according to Globocan 2018).</p>
        <list list-type="bullet">
          <list-item>
            <p>Familial adenomatous polyposis (FAP)&#x000a0;is related to the germline mutations of the APC gene.&#x000a0;FAP incidence represents 2 to 3 cases per million inhabitants, according to data from the Danish Polyposis Registry 2017.<xref ref-type="bibr" rid="article-22813.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Adenomatous polyposis syndromes (APC and MUTYH).<xref ref-type="bibr" rid="article-22813.r13">[13]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Juvenile polyposis coli: (BMPR1A and SMAD4).<xref ref-type="bibr" rid="article-22813.r14">[14]</xref> It is&#x000a0;estimated the incidence of 1 per one million&#x000a0;inhabitants.<xref ref-type="bibr" rid="article-22813.r15">[15]</xref><xref ref-type="bibr" rid="article-22813.r16">[16]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Peutz-Jeghers syndrome: (STK11/LKB1), is incidence represents&#x000a0;1.2 per one million inhabitants.<xref ref-type="bibr" rid="article-22813.r17">[17]</xref><xref ref-type="bibr" rid="article-22813.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>PTEN hamartoma tumor syndrome: (PHTS; PTEN).<xref ref-type="bibr" rid="article-22813.r19">[19]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cowden syndrome:(affecting the PTEN-gene).<xref ref-type="bibr" rid="article-22813.r20">[20]</xref>&#x000a0;It&#x000a0;is incidence represents 6 cases per ten million inhabitants.<xref ref-type="bibr" rid="article-22813.r21">[21]</xref><xref ref-type="bibr" rid="article-22813.r22">[22]</xref><xref ref-type="bibr" rid="article-22813.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>Turcot syndrome type II: The frequency is approximately 75% to 80% among all TSs. It is related to the APC gene mutation.<xref ref-type="bibr" rid="article-22813.r24">[24]</xref>&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Gardner syndrome: (involved&#x000a0;<italic toggle="yes">APC</italic>&#x000a0;gene).<xref ref-type="bibr" rid="article-22813.r25">[25]</xref>&#x000a0;It&#x000a0;is incidence represents 1 per one million people within the United States.<xref ref-type="bibr" rid="article-22813.r25">[25]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22813.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Colorectal cancer (CRC) is the third most common cancer and the fourth most common cause of cancer-related mortality globally. The estimated age-standardized incidence and mortality rates in 2018 worldwide for both sexes of all ages is 19.7 per 100000 inhabitants, and the mortality rate is 8.9 per 100000 patients, according to Globocan.&#x000a0;The incidence increases significantly by six times when it is related to obesity.<xref ref-type="bibr" rid="article-22813.r26">[26]</xref>&#x000a0;The hereditary CRC&#x000a0;occurs in those individuals with a family history of colorectal cancer with familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer, the most common being Lynch syndrome.<xref ref-type="bibr" rid="article-22813.r5">[5]</xref></p>
        <p>These are detected in 6% to 10% of all CRC diagnosed before age 50; that is, its incidence would be 2 per 100000 inhabitants in the world population.<xref ref-type="bibr" rid="article-22813.r1">[1]</xref><xref ref-type="bibr" rid="article-22813.r27">[27]</xref><xref ref-type="bibr" rid="article-22813.r1">[1]</xref> The risk of advanced neoplasia after a small tubular adenoma in the initial colonoscopy is four times higher in patients with a positive fecal immunochemical test.<xref ref-type="bibr" rid="article-22813.r28">[28]</xref> Additionally, the relative risk of colorectal cancer is higher when patients have a history of colon cancer than rectal cancer.<xref ref-type="bibr" rid="article-22813.r29">[29]</xref></p>
      </sec>
      <sec id="article-22813.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The mutational mechanisms associated with CRC are:</p>
        <p>
<bold>Genomic Instability</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold><italic toggle="yes">Instability Chromosome:</italic></bold> is the most common type found in 85% of the CRCs.<xref ref-type="bibr" rid="article-22813.r30">[30]</xref>&#x000a0;This mutation causes the loss of heterozygosity in tumor suppressor genes and mutations in proto-oncogenes.<xref ref-type="bibr" rid="article-22813.r31">[31]</xref> Mutations affect the following genes: APC, TP53, and K-ras, allelic loss of 18q, and aneuploidy.&#x000a0;For example, FAP develops cancer from this route (CRC risk 90% without colectomy and risk of extracolonic cancers 10 to 99 adenomas).<xref ref-type="bibr" rid="article-22813.r32">[32]</xref>&#x000a0; There are many mutations in the APC gene (a large &#x0201c;housekeeping&#x0201d; gene), including micro-deletions and frameshift mutations. More than 60% of the mutations are present at the 5&#x02032; ends of the exon on the 5q21 chromosome.<xref ref-type="bibr" rid="article-22813.r33">[33]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">Microsatellite instability:</italic></bold> It is present in 15% of CRC.<xref ref-type="bibr" rid="article-22813.r30">[30]</xref> It is caused by errors in the repair system due to DNA damage (MMR), mainly due to failure in base complementarity, which generates the expansion of short sequences in tandem and increases the number of mutations. The MMR system is made up of seven genes: hMLH1, hMLH3, hMSH2, hMSH3, hMSH6, hPMS1, and hPMS2; Currently, more than 500 different mutations have been described.<xref ref-type="bibr" rid="article-22813.r34">[34]</xref> For example, LS progresses to cancer from the aforementioned (Lifetime risk of CRC 70%).<xref ref-type="bibr" rid="article-22813.r32">[32]</xref> Cumulative incidence at 75 years for colorectal cancer were 46%, 43%, and 15% in path MLH1, MSH2, and MSH6 carriers, respectively.<xref ref-type="bibr" rid="article-22813.r35">[35]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p><italic toggle="yes"><bold>Epigenetic </bold></italic><bold>(DNA methylation)</bold> Methylation of CpG islands occurs in sporadic&#x000a0;CRC 15%<bold>,</bold>&#x000a0;and also it affects the expression of DNA repair genes or Mismatch genes.<xref ref-type="bibr" rid="article-22813.r36">[36]</xref><xref ref-type="bibr" rid="article-22813.r37">[37]</xref>&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-22813.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>We will focus on the two most frequent pathologies of hereditary colorectal cancer according to the polyposis classification:</p>
        <p><bold>HNPCC&#x000a0;</bold>-&#x000a0;<bold>Lynch syndrome (LS):</bold> Characteristically presents with flat polyps located in the right colon, which generate CRC and other cancers (endometrium, stomach, ovary, pancreas, ureter and renal pelvis, cerebral glioblastoma, biliary tract, cancer of the small intestine, sebaceous carcinomas and keratoacanthomas). Endometrial cancer occurs in relatively young women.<xref ref-type="bibr" rid="article-22813.r38">[38]</xref>&#x000a0;The diagnosis is challenging for the doctor due to the absence of pathognomonic clinical signs. A genetic study is required to establish the definitive diagnosis, so it is recommended to make a previous selection of these patients with the criteria of Bethesda and Amsterdam.<xref ref-type="bibr" rid="article-22813.r39">[39]</xref>&#x000a0;</p>
        <p><bold>HPCC) -&#x000a0;</bold><bold>Familial adenomatous polyposis (FAP):</bold> It is characterized by hundreds or thousands of precancerous adenomatous polyps, which generate CRC and other cancers, Also may occur extracolonic manifestations (desmoid tumor, osteomas, epidermoid cysts, papillary thyroid carcinoma, pancreatic carcinoma, gastric cancer, duodenal cancer, hepatobiliary and CNS tumors), this is due to mutations in the gene (APC), which controls cell proliferation and the regulation of a new long non-coding RNA (lncRNA).<xref ref-type="bibr" rid="article-22813.r40">[40]</xref>&#x000a0;It is classified clinically in two ways:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Classic FAP: </bold>Consists of the involvement of the entire colon with the appearance of 100 to 1000 adenomatous polyps, the age of onset of polyps comprises between 10 and 20 years of age; estimates are that the diagnosis of CRC corresponds to 30 to 40 years of age,&#x000a0;It correlates with the majority of cancers described above, which increases comorbidity.<xref ref-type="bibr" rid="article-22813.r41">[41]</xref><xref ref-type="bibr" rid="article-22813.r42">[42]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Attenuated FAP:&#x000a0;</bold>Frequently affects the right colon, with an appearance of 10 to 100 adenomatous polyps, the age of onset of polyps between 20 to 30 years of age; estimates are the diagnosis of CRC corresponds to 40 to 50 years of age. It commonly carries associations with gastric, duodenal, and thyroid cancer.<xref ref-type="bibr" rid="article-22813.r43">[43]</xref><xref ref-type="bibr" rid="article-22813.r44">[44]</xref>&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22813.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnostic basis of hereditary CRC is from clinical findings, family history, genetic tests, and diagnostic images (see<bold>&#x000a0;Table.</bold>&#x000a0;Colorectal Carcinoma Screening Guidelines).</p>
        <p><bold>Physical examination:</bold>&#x000a0;Should include evaluation of adenopathies, mainly supraclavicular, cervical and axillary, digital rectal examination, abdominal palpation in search of masses or ascites, hepatomegaly suggesting a hepatic metastatic compromise.</p>
        <p><bold>Total&#x000a0;colonoscopy:&#x000a0;</bold>It is a gold standard technique since it allows the resection and biopsy of the lesions observed during the procedure.<xref ref-type="bibr" rid="article-22813.r45">[45]</xref>&#x000a0;Moreover, endoscopy with a colonic capsule is a promising technique for noninvasive colon screening; however, it is a risk to detect polyps and not be able to biopsy them.<xref ref-type="bibr" rid="article-22813.r46">[46]</xref></p>
        <p><bold>Family history</bold><bold>:&#x000a0;</bold>more than one criterion raises suspicion of LS.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Modified Bethesda criteria,</bold>&#x000a0;which are:&#x000a0; &#x000a0; 
<list list-type="bullet"><list-item><p>Patients with CRC belong to families that meet the criteria of Amsterdam</p></list-item><list-item><p>Patients with two neoplasms associated with HNPCC, including synchronous or metachronous CRC and extracolonic cancer (endometrium, ovary, gastric, hepatobiliary, small intestine, ureter, or renal pelvis)</p></list-item><list-item><p>Patients with CRC and a first-degree relative with CRC, extracolonic neoplasm associated with HNPCC or colorectal adenoma; one of the cancers diagnosed before 50 and the adenoma before 40 years of age</p></list-item><list-item><p>Patients with CRC or endometrial cancer are diagnosed before 50 years of age</p></list-item><list-item><p>Patients with CRC in the right colon and histologically undifferentiated are diagnosed before 50</p></list-item><list-item><p>Patients with CCR-type cells in the signet ring (composed of more than 50% of signet ring cells) were diagnosed before 50</p></list-item><list-item><p>Patients with colorectal adenoma are diagnosed before 40 years of age<xref ref-type="bibr" rid="article-22813.r47">[47]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Amsterdam criteria II,&#x000a0;</bold>which are:
<list list-type="bullet"><list-item><p>Three or more relatives affected by a neoplasm associated with HNPCC (CRC, cancer of the endometrium, small intestine, ureter, or renal pelvis), one of them being a first-degree relative of the other two, and;</p></list-item><list-item><p>Two or more successive generations were affected, and;</p></list-item><list-item><p>One or more relatives affected by CRC were diagnosed before 50 years of age, and;</p></list-item><list-item><p>Exclusion of FAP in cases of CCR.<xref ref-type="bibr" rid="article-22813.r48">[48]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p><bold>Molecular and genetic testing:</bold> LS&#x000a0;Diagnosis is made by tumor testing with<italic toggle="yes">&#x000a0;MMR immunohistochemistry</italic> and &#x000a0;<italic toggle="yes">PCR for MSI (microsatellite instability)</italic>, a genetic phenotype that characterizes these tumors. Therefore, having a positive genetic test (MSI), a positive Bethesda or Amsterdam item, and the tumor located on the right side of the colon are highly suspicious findings of Lynch syndrome.<xref ref-type="bibr" rid="article-22813.r49">[49]</xref>&#x000a0;When colonic polyposis presents in a single person with a negative family history, consideration should be to test for a de novo APC mutation; if negative, follow with MUTYH genetic testing when colonic polyposis is present only in siblings, consider recessive inheritance, and test for MUTYH first.<xref ref-type="bibr" rid="article-22813.r40">[40]</xref></p>
        <p><bold>Diagnostic Imaging:&#x000a0;</bold>It is suggested to perform computed tomography with the contrast of the chest, abdomen, and pelvis to estimate the stage of the disease in all patients with colorectal cancer. Additionally, It is suggested to perform computed tomography or magnetic resonance imaging of the pelvis to assess the status of the mesorectal margin in selected cases.</p>
        <p>Specific aspects of individuals' family history of CRC would influence the age at which, planning to begin screening and the frequency of screening. Following details with the family history of the number of first-degree relatives should be considered before planning for a screening schedule;</p>
        <list list-type="order">
          <list-item>
            <p>Established diagnosis of CRC</p>
          </list-item>
          <list-item>
            <p>Advanced polyp that harbors any of the following characteristics:
<list list-type="bullet"><list-item><p>Adenoma size of equal to or greater than 1 cm</p></list-item><list-item><p>Presence of high-grade dysplasia</p></list-item><list-item><p>Adenoma with a villous component</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Advanced sessile serrated lesion with any of the following characteristics:
<list list-type="bullet"><list-item><p>Sessile polyp with a size equal to or greater than 1 cm</p></list-item><list-item><p>Serrated adenoma with equal or greater than 1 cm size</p></list-item><list-item><p>Presence of dysplasia in a sessile serrated polyp</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>According to the response to the above questions, the following screening schedules are recommended. If&#x000a0;equal to or more than one first-degree relative is affected, the screening is to be initiated either at the age of 40 or at the age equal to 10 years younger than the affected FDR, whichever comes earlier. Moreover, a continuous schedule plan with either colonoscopy every five years or&#x000a0;annual fecal immunochemical testing (FIT) are recommended.</p>
        <p>Consequently, if the first-degree relative has a polyp without a well-established tissue diagnosis of either an advanced adenoma or a serrated polyp, the individual would be categorized as average risk.&#x000a0;</p>
        <p>
<bold>High-Risk Syndrome Screenings</bold>
</p>
        <p>Specific screening schedules should be planned for individuals with Lynch-associated cancers. The schedule should be organized based on the following characteristics; 1. personal and family history of cancer, 2. the gene affected, and 3. the mode of ascertainment of the familial mutation. According to some expert opinions, and due to the significantly lower lifetime cancer risk for carriers of germline&#x000a0;<italic toggle="yes">PMS2&#x000a0;</italic>mutations, screening recommendations must be tailored to the MMR gene alone. Moreover,&#x000a0;a later mean age of colorectal cancer (CRC) onset in germline&#x000a0;<italic toggle="yes">MSH6</italic>&#x000a0;carriers should dictate a modified screening schedule.</p>
        <p>Collectively, screening is recommended for the following individuals considering the&#x000a0;Lynch-associated cancers:</p>
        <list list-type="order">
          <list-item>
            <p>Individuals with either a pathogenic germline mutation in the DNA mismatch repair (MMR) genes or&#x000a0;epithelial cellular adhesion molecule (EPCAM)<italic toggle="yes">&#x000a0;</italic>deletions that can inactivate Mutation S Homolog 2 (MSH2)</p>
          </list-item>
          <list-item>
            <p>Individuals at risk for Lynch syndrome, including individuals in families meeting Amsterdam I or II criteria and individuals meeting revised Bethesda guidelines</p>
          </list-item>
          <list-item>
            <p>High-risk individuals with an equal or greater than 2.5 to 5 % risk for MMR mutation according to the prediction models<xref ref-type="bibr" rid="article-22813.r50">[50]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22813.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Management of patients with HCCR is multidisciplinary and mainly stems from patients' specific findings.&#x000a0;</p>
        <p><bold>Chemotherapy:&#x000a0;</bold>Depending on their genetic mutation, hereditary CRCs may respond differently to traditional chemotherapy regimens. The microsatellite instability in many cases reflects a difference in the biological characteristics of the tumor, possibly with a unique susceptibility to immunotherapy.<xref ref-type="bibr" rid="article-22813.r51">[51]</xref><xref ref-type="bibr" rid="article-22813.r52">[52]</xref>&#x000a0;High-risk rectal cancers require neoadjuvant chemotherapy along with radiotherapy.<xref ref-type="bibr" rid="article-22813.r53">[53]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Current ASCO, NCCN, and ESMO guidelines strongly recommend adjuvant therapy for selected stage II with high-risk/pMMR/MSI-S disease and all stage III (node-positive).&#x000a0;The guidelines advocate administering adjuvant chemotherapy (FOLFOX or CAPOX) within 6 to 8 weeks after surgical resection, pending recovery of the patient's health.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>FOLFOX (5-fluorouracil plus + leucovorin plus +oxaliplatin) is the first-line modern chemotherapy for metastatic disease more effective than the obsolete single-agent chemotherapy (5-fluorouracil) (HR for SLP: 0.59, 95% CI 0.49 to 0.73, 2 RCT),&#x000a0; (HR for OS: 0.69, 95% CI 0.51 to 0.94, 1 RCT).<xref ref-type="bibr" rid="article-22813.r54">[54]</xref></p>
          </list-item>
          <list-item>
            <p>FOLFIRI&#x000a0;(5-fluorouracil plus + leucovorin plus + irinotecan) is the second most effective chemotherapy in metastatic CRC and is either first or second line. (HR for OS: 0.58, 95% CI 0.43 to 0.80, 1 RCT).</p>
          </list-item>
          <list-item>
            <p>Combinations based on irinotecan were more effective than irinotecan alone (HR for PFS: 0.68, 95% CI 0.60 to 0.76, 6 RCT) [Level II].&#x000a0;Targeted agents increased the efficacy of conventional chemotherapy when considered together (HR for OS: 0.84, 95% CI 0.77 to 0.91, 6 RCT) and when bevacizumab alone (HR for PFS: 0.67, 95% CI 0.60 to 0.75, 4 RCT).<xref ref-type="bibr" rid="article-22813.r54">[54]</xref></p>
          </list-item>
          <list-item>
            <p>In metastatic colorectal cancer, monoclonal antibodies are used (bevacizumab, cetuximab, and panitumumab)&#x000a0; in combination with chemotherapy. There is a distinct benefit in the addition of bevacizumab to chemotherapy for tumors on the right side of cetuximab to chemotherapy for tumors on the left side (for RAS wild-type tumors) to oxaliplatin- and irinotecan-based regimens which can be a consideration for first-line therapy.<xref ref-type="bibr" rid="article-22813.r55">[55]</xref></p>
          </list-item>
          <list-item>
            <p>A meta-analysis including the TAILOR and the PRIME study suggests that primary tumor location predicted a survival benefit when adding the anti-epidermal growth factor receptor antibody to FOLFOX regimen in RAS &#x00026; NRAS-wild metastatic CRC patients (OS, HR for left-sided: 0.71; 95% CI: 0.59-0.85; P=.0002 and HR for right-sided: 0.90; 95% CI: 0.65-1.25; P=.53). The efficacy was similar in patients with wild molecular characteristics RAS / BRAF.<xref ref-type="bibr" rid="article-22813.r56">[56]</xref></p>
          </list-item>
        </list>
        <p><bold>Radiotherapy:</bold>&#x000a0;Preoperative radiotherapy&#x000a0;(hypofractionated) with chemotherapy is recommended in patients with stage II and III rectal cancer or unresectable residual tumor (positive margins), according to the report of anatomopathological findings of the surgical specimen.<xref ref-type="bibr" rid="article-22813.r57">[57]</xref> The use of radiotherapy is limited to palliative therapy for selected cases of metastasis (bone, brain).<xref ref-type="bibr" rid="article-22813.r58">[58]</xref>&#x000a0;</p>
        <p><bold>Surgery:</bold> The appropriate surgical option for patients with colon cancer and LS (total abdominal colectomy or segmental colectomy with ileorectal anastomosis) will depend on the risk factors. The surgical preferences of the patient, with special emphasis on the age of the patient and the capacity of the patient to follow intensive surveillance,<xref ref-type="bibr" rid="article-22813.r59">[59]</xref>&#x000a0;but currently, segmental resection is the most performed surgical method in these cases.<xref ref-type="bibr" rid="article-22813.r60">[60]</xref>&#x000a0;Also, patients should be offered the option of prophylactically extended surgery (hysterectomy and oophorectomy) if possible in postmenopausal women.<xref ref-type="bibr" rid="article-22813.r61">[61]</xref><xref ref-type="bibr" rid="article-22813.r62">[62]</xref>&#x000a0;</p>
        <p>In FAP, prophylactic colectomy is an important option to prevent CRC.<xref ref-type="bibr" rid="article-22813.r63">[63]</xref> The preventive surgical approach is limited for patients with attenuated FAP, delayed colectomy time, and increased standardization of laparoscopic surgery.<xref ref-type="bibr" rid="article-22813.r64">[64]</xref>&#x000a0;However, surveillance and surgical management planning should follow a thorough assessment of familial cancer risk.<xref ref-type="bibr" rid="article-22813.r65">[65]</xref></p>
      </sec>
      <sec id="article-22813.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Gardner syndrome: </bold>is a variant of FAP and is an autosomal dominant inherited disease characterized by multiple intestinal polyps together with extra-intestinal manifestations including multiple osteomas, connective tissue tumors, thyroid carcinomas, hypertrophied pigmented epithelium of the retina, and also frequent retained supernumerary teeth and odontomas.<xref ref-type="bibr" rid="article-22813.r25">[25]</xref>&#x000a0;This condition carries a high risk of developing colon cancer.<xref ref-type="bibr" rid="article-22813.r66">[66]</xref>&#x000a0;</p>
        <p><bold>Muir-Torre syndrome:</bold>&#x000a0;MTS&#x000a0;is a rare subtype of LS&#x000a0;characterized by sebaceous neoplasms of the skin and visceral malignancies, with colonic carcinoma being the most common.<xref ref-type="bibr" rid="article-22813.r67">[67]</xref></p>
        <p><bold>Turcot syndrome: </bold>TS&#x000a0;is the association of primary brain tumors.&#x000a0;It divides into two subtypes: TS type I (Intestinal polyps are large, fewer in number than 100, and are apt to undergo a malignant change. Associated brain tumor is usually a glioblastoma or an astrocytoma.) and TS&#x000a0;type II (Familial adenomatous polyposis-associated type. There is a predisposition to the development of medulloblastoma.)<xref ref-type="bibr" rid="article-22813.r68">[68]</xref>&#x000a0;Tumors can also arise from the spinal cord, manifesting with symptoms of spinal cord compression.<xref ref-type="bibr" rid="article-22813.r69">[69]</xref></p>
        <p><bold>Juvenile polyposis coli:</bold> JPC is a rare disease characterized by juvenile hamartomatous polyps in the gastrointestinal tract.&#x000a0;The lifetime risk of CRC is 20%.<xref ref-type="bibr" rid="article-22813.r70">[70]</xref>&#x000a0;JPC is diagnosed with more than five juvenile polyps in the colon and/or rectum; the presence of juvenile polyps along the digestive tract, including the stomach; the presence of any number of juvenile polyps in association with a family history of JIP.<xref ref-type="bibr" rid="article-22813.r71">[71]</xref>&#x000a0;Clinical signs include isolated rectal bleeding, anemia, abdominal pain, intestinal invaginations, diarrhea, rectal prolapse, and spontaneous anal elimination of polyps in juvenile polyposis coli and generalized juvenile polyposis. Other associated signs may include growth retardation and edema.<xref ref-type="bibr" rid="article-22813.r72">[72]</xref></p>
        <p><bold>Peutz-Jeghers Syndrome:</bold>&#x000a0;PJS is characterized by the pigmentation of mucocutaneous melanin and multiple gastrointestinal polyposes. The clinical manifestations mainly included black spots, abdominal pain, and anemia.<xref ref-type="bibr" rid="article-22813.r73">[73]</xref>&#x000a0;These polyps have a higher risk of developing GI cancers of the colorectal, pancreatic, and gastric organs, in addition to a wide variety of non-GI epithelial malignancies, such as cancers of the breast, uterus, cervix, and ovary, testicular, and lung (see&#x000a0;<bold>Image.</bold>&#x000a0;Breast Cancer Metastasis Sites).&#x000a0;The lifetime risk of CRC is 39%.<xref ref-type="bibr" rid="article-22813.r74">[74]</xref>&#x000a0;Patients with PJS present a high risk of intussusception and should receive regular follow-up due to the high risk of cancer and the possibility of relapse.<xref ref-type="bibr" rid="article-22813.r75">[75]</xref></p>
        <p><bold>Hamartoma tumor syndrome:&#x000a0;</bold>This is called PTEN (PHTS).<xref ref-type="bibr" rid="article-22813.r76">[76]</xref> PTEN correlates with multiple benign diseases (macrocephaly, Hashimoto's thyroiditis, mucocutaneous hamartomas, colon polyps, and vascular malformations) and malignant tumors (breast, thyroid, renal, endometrial, and colon cancer),<xref ref-type="bibr" rid="article-22813.r76">[76]</xref>&#x000a0; as well as neurodevelopmental disorders such as autism.<xref ref-type="bibr" rid="article-22813.r77">[77]</xref>&#x000a0;PHTS patients may also demonstrate an increased risk of immunological dysregulation, including autoimmunity and immune deficiencies.<xref ref-type="bibr" rid="article-22813.r19">[19]</xref></p>
        <p><bold>Cowden syndrome:</bold>&#x000a0;CS classically is characterized by multiple hamartomas that can occur in any organ, macrocephaly, mucocutaneous lesions, an increased risk of breast and thyroid cancers, and ovarian and colon cancer.&#x000a0;The lifetime risk of CRC is 13%.<xref ref-type="bibr" rid="article-22813.r22">[22]</xref><xref ref-type="bibr" rid="article-22813.r78">[78]</xref></p>
        <p><bold>Bannayan-Riley-Ruvalcaba syndrome:&#x000a0;</bold>BRRS&#x000a0;is a congenital disorder frequently characterized by hamartomatous intestinal polyps, lipomas, macrocephaly, and genital lentiginosis. BRRS patients with a PTEN mutation share the same risk of developing cancer as patients with CS.<xref ref-type="bibr" rid="article-22813.r79">[79]</xref></p>
        <p><bold>Proteus syndromes:&#x000a0;</bold>PS is a disorder characterized by progressive excessive growth at the level of the skeleton, skin, fat, and central nervous system, with few hamartomatous polyps. Complications include hemimegaloencephaly, bullous lung disease, pulmonary embolism, and deep vein thrombosis. The tumors are usually benign, although there are reports of rare cases of malignant tumors.<xref ref-type="bibr" rid="article-22813.r80">[80]</xref></p>
        <p><bold>Solamen syndrome: </bold>The<bold>&#x000a0;</bold>term 'SOLAMEN syndrome' "Segmental Overgrowth, Lipomatosis, Arteriovenous Malformation, and Epidermal Nevus." These patients are carriers of germline mutations in the phosphatase and PTEN homologs.<xref ref-type="bibr" rid="article-22813.r81">[81]</xref></p>
      </sec>
      <sec id="article-22813.s10" sec-type="Surgical Oncology">
        <title>Surgical Oncology</title>
        <p>Surgical management should be planned considering the specific hereditary colorectal cancer. Accordingly, the treatment of choice for patients with attenuated and familial adenomatous polyposis, with a significantly large number of rectal adenomas, is proctocolectomy with ileostomy or ileal-pouch anal anastomosis (IPAA). However, the timing of treatment should be individualized. On the other hand, if all of the rectal adenomas greater than 5 mm in size can be removed endoscopically, rectal sparing alternatives with total colectomy with ileorectal anastomosis (TAC-IRA) is the preferred management. Moreover, in patients with greater than 20-lifetime adenomas, MUTYH-associated polyposis (MAP) should be considered. Accordingly, patients with biallelic&#x000a0;<italic toggle="yes">MYH</italic>&#x000a0;mutations are recommended for annual colonoscopy and polypectomy for polyps that can be removed endoscopically.<xref ref-type="bibr" rid="article-22813.r82">[82]</xref></p>
      </sec>
      <sec id="article-22813.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In their study, Lee and his colleagues indicated that those with sporadic colorectal cancer (CRC) and a family history of CRC had better overall survival but a cancer recurrence similar to those who did not have a CRC family history.<xref ref-type="bibr" rid="article-22813.r83">[83]</xref></p>
        <p>CRC survivors (5 to 10 years post-diagnosis) reported overall good health-related quality of life but significantly poorer social functioning and more problems with dyspnea, constipation, diarrhea, and finances than controls, mainly among younger subjects.<xref ref-type="bibr" rid="article-22813.r84">[84]</xref></p>
      </sec>
      <sec id="article-22813.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Severe complications during colonoscopy represent the most important adverse effect of colorectal cancer screening programs. The immediate complication occurred in 3.3%, as perforation and hemorrhagic events. However, the following factors increase the risk of early and late complications, including a history of colon disease, a history of anticoagulation, a history of pelvic surgery or abdominal radiotherapy, and a history of perforation.<xref ref-type="bibr" rid="article-22813.r85">[85]</xref></p>
        <p>After a total colectomy, systemic complications can occur in 22%, mainly in those older than 65 years, due to significant comorbidities, while the incidence of surgical complications was 8%, such as anastomotic leakage, major infections in the wound, and postoperative hemorrhage.<xref ref-type="bibr" rid="article-22813.r86">[86]</xref></p>
      </sec>
      <sec id="article-22813.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>There is a need for educational efforts to raise awareness about CRC, particularly among the young. There is also a need to improve adherence to screening in young patients eligible for screening and to emphasize early evaluation of symptoms. These are&#x000a0;essential steps to decreasing the burden of CRC in younger patients.<xref ref-type="bibr" rid="article-22813.r87">[87]</xref>&#x000a0;</p>
        <p>Good lifestyle and dietary habits are recommended to reduce the most critical factor in colorectal carcinogenesis starting in the early stages of life.<xref ref-type="bibr" rid="article-22813.r88">[88]</xref></p>
      </sec>
      <sec id="article-22813.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional approach includes a gastroenterologist, oncologist, colorectal surgeon, primary care provider, nurse practitioner (physician and mid-level practitioners), geneticist, nurse genetics counselor, other nursing staff, and pharmacist. Consider offering genetic testing to people with suspected hereditary colorectal cancer and their family members after genetic counseling.<xref ref-type="bibr" rid="article-22813.r89">[89]</xref>&#x000a0;Suggestions are that in individuals with a family history in the first degree of classical FAP, the screening strategy is annual colonoscopy from 12 to 15 years, up to 30 to 35 years of age, and then it is suggested to continue screening every five years.<xref ref-type="bibr" rid="article-22813.r90">[90]</xref><xref ref-type="bibr" rid="article-22813.r91">[91]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>In the population with suspicion or family history of HNPCC, suggestions are that the screening strategy is a colonoscopy every two years, from 20 to 25 years, or five to ten years before the age of the youngest case diagnosed in the family.<xref ref-type="bibr" rid="article-22813.r92">[92]</xref><xref ref-type="bibr" rid="article-22813.r93">[93]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Studies consistently report that registration and screening reduce CRC incidence and mortality in patients with FAP and LS.<xref ref-type="bibr" rid="article-22813.r94">[94]</xref>&#x000a0;[Level 2]</p>
          </list-item>
          <list-item>
            <p>The MSI test is an effective screening test for Lynch syndrome. However, it must correlate with the panel of markers used or the thresholds used to denote a positive test.<xref ref-type="bibr" rid="article-22813.r95">[95]</xref>&#x000a0;[Level 2]&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The&#x000a0;studies&#x000a0;indicate that in adenomatous polyposis coli patients with APC promoter, hypermethylation is an early event in carcinogenesis of CRC and could be a valuable diagnostic marker for early-stage CRC.<xref ref-type="bibr" rid="article-22813.r96">[96]</xref><xref ref-type="bibr" rid="article-22813.r97">[97]</xref>&#x000a0;[Level 2]&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Currently, the evidence of chemoprevention is for NSAIDs, sulindac, and aspirin in low doses that reduce the progression of polyps and the long-term incidence of colorectal cancers in patients with&#x000a0;FAP&#x000a0; and HNPCC, respectively.<xref ref-type="bibr" rid="article-22813.r98">[98]</xref>&#x000a0;[Level 2]&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Strict vigilance is necessary for the syndromes associated with CCR and extracolonic&#x000a0;manifestations, especially LS with endometrial cancer, as well as those mentioned in the differential diagnosis section.<xref ref-type="bibr" rid="article-22813.r99">[99]</xref></p>
          </list-item>
          <list-item>
            <p>The risk factors that increase mortality are advanced age, male sex, African-American race, elevated CEA, and not undergoing curative surgery. Likewise, patients with CRC have an association with an increased risk of cardiovascular death, especially during the first year after diagnosis.<xref ref-type="bibr" rid="article-22813.r100">[100]</xref>&#x000a0;[Level 2]</p>
          </list-item>
          <list-item>
            <p>Overall, FOLFOX was the most effective first-line treatment&#x000a0;[Level I], and FOLFIRI plus cetuximab (KRAS/NRAS wild) was the most effective treatment in terms of long-term survival, Wang and colleagues, in their analysis of 75 RCTs published after 1997. This treatment is preferable for patients with CRC in clinical practice.<xref ref-type="bibr" rid="article-22813.r101">[101]</xref>&#x000a0;[Level 1]</p>
          </list-item>
          <list-item>
            <p>The use&#x000a0;of bevacizumab represents hope for increased survival and a chance of metastasectomy for patients with metastatic CRC. However, serious adverse events are associated with its use, especially severe hypertension and gastrointestinal perforation, that merit consideration.<xref ref-type="bibr" rid="article-22813.r102">[102]</xref>&#x000a0;[Level 1]&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The treating physician should recommend a diet rich in dietary fiber because it decreases CRC risk and post-operative relapses.<xref ref-type="bibr" rid="article-22813.r103">[103]</xref><xref ref-type="bibr" rid="article-22813.r104">[104]</xref><xref ref-type="bibr" rid="article-22813.r105">[105]</xref> Currently, there is inadequate data to support the benefits of exercise in the field of colorectal surgery.<xref ref-type="bibr" rid="article-22813.r106">[106]</xref><xref ref-type="bibr" rid="article-22813.r107">[107]</xref>&#x000a0;[Level 3]&#x000a0;</p>
          </list-item>
        </list>
        <p>Irrespective of the path of treatment (chemotherapy, surgery, etc.), all members of the interprofessional team must follow the patient, off counsel, and alert other team members as necessary when they note a change in the patient's status, including adverse drug events or therapeutic failure or relapse, recording their observations in the patient's medical record. This way, the appropriate measures can be taken to change the treatment regimen to optimize patient outcomes. The interprofessional approach to patient care will benefit the patient and ensure proper therapeutic care. [Level 5]</p>
      </sec>
      <sec id="article-22813.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22813&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22813">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/a-review-of-hereditary-colorectal-cancers-familial-colon-cancer/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22813">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22813/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22813">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22813.s16">
        <fig id="article-22813.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Breast Cancer Metastasis Sites Medical Gallery of Mikael H&#x000e4;ggstr&#x000f6;m, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://commons.wikimedia.org/wiki/File:Metastasis_sites_for_common_cancers.svg">Public Domain</ext-link>, via Wikimedia Commons&#x000a0;</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Metastasis_sites_for_common_cancers.svg" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22813.s17">
        <fig id="article-22813.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Colorectal Carcinoma Screening Guidelines Canadian Task Force on Preventive Health Care.&#x000a0;Recommendations on screening for colorectal cancer in primary care. <italic toggle="yes">CMAJ.</italic>&#x000a0;2016;188(5):340-348.&#x000a0;doi: https://doi.org/10.1503/cmaj.151125.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Colorectal__Carcinoma__Screening__Guidelines__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22813.s18">
        <title>References</title>
        <ref id="article-22813.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Valle</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vilar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tavtigian</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Stoffel</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine.</article-title>
            <source>J Pathol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>247</volume>
            <issue>5</issue>
            <fpage>574</fpage>
            <page-range>574-588</page-range>
            <pub-id pub-id-type="pmid">30584801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katballe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wikman</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>&#x000d8;rntoft</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Laurberg</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients.</article-title>
            <source>Gut</source>
            <year>2002</year>
            <month>Jan</month>
            <volume>50</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-51</page-range>
            <pub-id pub-id-type="pmid">11772966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Balderacchi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Desani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Saverimuthu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Win</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and characteristics of hereditary non-polyposis colorectal cancer (HNPCC) syndrome in immigrant Asian colorectal cancer patients.</article-title>
            <source>BMC Cancer</source>
            <year>2017</year>
            <month>Dec</month>
            <day>13</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>843</fpage>
            <pub-id pub-id-type="pmid">29237405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kanth</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Grimmett</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Champine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Samadder</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>112</volume>
            <issue>10</issue>
            <fpage>1509</fpage>
            <page-range>1509-1525</page-range>
            <pub-id pub-id-type="pmid">28786406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porkka</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lahtinen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ahtiainen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>B&#x000f6;hm</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Kuopio</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eldfors</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mecklin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Sepp&#x000e4;l&#x000e4;</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Peltom&#x000e4;ki</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Epidemiological, clinical and molecular characterization of Lynch-like syndrome: A population-based study.</article-title>
            <source>Int J Cancer</source>
            <year>2019</year>
            <month>Jul</month>
            <day>01</day>
            <volume>145</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <page-range>87-98</page-range>
            <pub-id pub-id-type="pmid">30575961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sui</surname>
                <given-names>QQ</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>XD</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>ZZ</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>A frameshift mutation in exon 19 of MLH1 in a Chinese Lynch syndrome family: a pedigree study.</article-title>
            <source>J Zhejiang Univ Sci B</source>
            <string-date>2019 Jan.</string-date>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>105</fpage>
            <page-range>105-108</page-range>
            <pub-id pub-id-type="pmid">30614234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taranc&#x000f3;n-Diez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>B&#x000fc;ttner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Friedrichs</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Enhanced Tumoral MLH1-Expression in MLH1-/PMS2-Deficient Colon Cancer Is Indicative of Sporadic Colon Cancer and Not HNPCC.</article-title>
            <source>Pathol Oncol Res</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>1435</fpage>
            <page-range>1435-1439</page-range>
            <pub-id pub-id-type="pmid">30613919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schierbeck</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vestergaard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bygum</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Skin Cancer Associated Genodermatoses: A Literature Review.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2019</year>
            <month>Apr</month>
            <day>01</day>
            <volume>99</volume>
            <issue>4</issue>
            <fpage>360</fpage>
            <page-range>360-369</page-range>
            <pub-id pub-id-type="pmid">30653245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>XR</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>XH</given-names>
              </name>
            </person-group>
            <article-title>[Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].</article-title>
            <source>Zhonghua Bing Li Xue Za Zhi</source>
            <year>2018</year>
            <month>Nov</month>
            <day>08</day>
            <volume>47</volume>
            <issue>11</issue>
            <fpage>827</fpage>
            <page-range>827-833</page-range>
            <pub-id pub-id-type="pmid">30423605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hampel</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Population Screening for Hereditary Colorectal Cancer.</article-title>
            <source>Surg Oncol Clin N Am</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>319</fpage>
            <page-range>319-325</page-range>
            <pub-id pub-id-type="pmid">29496092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cruz-Correa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Mayoral</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dutil</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Echenique</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mosquera</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rivera-Rom&#x000e1;n</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Umpierre</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rodriguez-Quilichini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gonzalez-Pons</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olivera</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Pardo</surname>
                <given-names>S</given-names>
              </name>
              <collab>Puerto Rico Clinical Cancer Genetics Consortia</collab>
            </person-group>
            <article-title>Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines.</article-title>
            <source>Hered Cancer Clin Pract</source>
            <year>2017</year>
            <volume>15</volume>
            <fpage>3</fpage>
            <pub-id pub-id-type="pmid">28127413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karstensen</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Burisch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pommergaard</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Aalling</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>H&#x000f8;jen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jespersen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>B&#x000fc;low</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Colorectal Cancer in Individuals With Familial Adenomatous Polyposis, Based on Analysis of the Danish Polyposis Registry.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>17</volume>
            <issue>11</issue>
            <fpage>2294</fpage>
            <page-range>2294-2300.e1</page-range>
            <pub-id pub-id-type="pmid">30743005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sutcliffe</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Bartenbaker Thompson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stettner</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Susswein</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Hruska</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis.</article-title>
            <source>Fam Cancer</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-209</page-range>
            <pub-id pub-id-type="pmid">30604180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosty</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The Role of the Surgical Pathologist in the Diagnosis of Gastrointestinal Polyposis Syndromes.</article-title>
            <source>Adv Anat Pathol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-13</page-range>
            <pub-id pub-id-type="pmid">28901964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brosens</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Langeveld</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>van Hattem</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Giardiello</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Offerhaus</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Juvenile polyposis syndrome.</article-title>
            <source>World J Gastroenterol</source>
            <year>2011</year>
            <month>Nov</month>
            <day>28</day>
            <volume>17</volume>
            <issue>44</issue>
            <fpage>4839</fpage>
            <page-range>4839-44</page-range>
            <pub-id pub-id-type="pmid">22171123</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raab</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sanhaji</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matthess</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>H&#x000f6;rlin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lorenz</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>D&#x000f6;tsch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Habbe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Waidmann</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Kurunci-Csacsko</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Firestein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Strebhardt</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells.</article-title>
            <source>Nat Commun</source>
            <year>2018</year>
            <month>Mar</month>
            <day>16</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>1106</fpage>
            <pub-id pub-id-type="pmid">29549256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spoto</surname>
                <given-names>CPE</given-names>
              </name>
              <name>
                <surname>Gullo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Carneiro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Montgomery</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Brosens</surname>
                <given-names>LAA</given-names>
              </name>
            </person-group>
            <article-title>Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing.</article-title>
            <source>Semin Diagn Pathol</source>
            <year>2018</year>
            <month>May</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>170</fpage>
            <page-range>170-183</page-range>
            <pub-id pub-id-type="pmid">29397239</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sengupta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bose</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Peutz-Jeghers Syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>2019</year>
            <month>Jan</month>
            <day>31</day>
            <volume>380</volume>
            <issue>5</issue>
            <fpage>472</fpage>
            <pub-id pub-id-type="pmid">30699321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eissing</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ripken</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schreibelt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Westdorp</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ligtenberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Netea-Maier</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Netea</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>IJM</given-names>
              </name>
              <name>
                <surname>Hoogerbrugge</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>PTEN Hamartoma Tumor Syndrome and Immune Dysregulation.</article-title>
            <source>Transl Oncol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>361</fpage>
            <page-range>361-367</page-range>
            <pub-id pub-id-type="pmid">30504085</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yauy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Imbert-Bouteille</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bubien</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lindet-Bourgeois</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rathat</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Perrochia</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>MacGrogan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Longy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bessis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tinat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Baert-Desurmont</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Blanluet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perre</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Baudry</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pujol</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Corsini</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Ovarian Clear Cell Carcinoma in Cowden Syndrome.</article-title>
            <source>J Natl Compr Canc Netw</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-11</page-range>
            <pub-id pub-id-type="pmid">30659124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pilarski</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Cowden syndrome: a critical review of the clinical literature.</article-title>
            <source>J Genet Couns</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-27</page-range>
            <pub-id pub-id-type="pmid">18972196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r22">
          <label>22</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Garofola</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jamal</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <chapter-title>Cowden Disease</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>3</month>
            <day>27</day>
            <pub-id pub-id-type="pmid">30252240</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sohrabi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zamani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ajdarkosh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rakhshani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ameli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mohamadnejad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kabir</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hemmasi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Khonsari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Motamed</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of colorectal polyps in a group of subjects at average-risk of colorectal cancer undergoing colonoscopic screening in Tehran, Iran between 2008 and 2013.</article-title>
            <source>Asian Pac J Cancer Prev</source>
            <year>2014</year>
            <volume>15</volume>
            <issue>22</issue>
            <fpage>9773</fpage>
            <page-range>9773-9</page-range>
            <pub-id pub-id-type="pmid">25520103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buecher</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Colorectal adenomatous polyposis syndromes: Genetic determinism, clinical presentation and recommendations for care.</article-title>
            <source>Bull Cancer</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>103</volume>
            <issue>2</issue>
            <fpage>199</fpage>
            <page-range>199-209</page-range>
            <pub-id pub-id-type="pmid">26805944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r25">
          <label>25</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Charifa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jamil</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Sathe</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <chapter-title>Gardner Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">29493967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sung</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Jemal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry.</article-title>
            <source>Lancet Public Health</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>e137</fpage>
            <page-range>e137-e147</page-range>
            <pub-id pub-id-type="pmid">30733056</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Venugopal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stoffel</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Colorectal Cancer in Young Adults.</article-title>
            <source>Curr Treat Options Gastroenterol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-98</page-range>
            <pub-id pub-id-type="pmid">30712157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Symonds</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Cole</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meng</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Woodman</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Cock</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bampton</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The significance of the small adenoma: a longitudinal study of surveillance colonoscopy in an Australian population.</article-title>
            <source>Eur J Gastroenterol Hepatol</source>
            <year>2019</year>
            <month>May</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>563</fpage>
            <page-range>563-569</page-range>
            <pub-id pub-id-type="pmid">30672827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hemminki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sundquist</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hemminki</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Familial Associations of Colon and Rectal Cancers With Other Cancers.</article-title>
            <source>Dis Colon Rectum</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>62</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-195</page-range>
            <pub-id pub-id-type="pmid">30640834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>The impact of microsatellite stability status in colorectal cancer.</article-title>
            <source>Curr Probl Cancer</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>548</fpage>
            <page-range>548-559</page-range>
            <pub-id pub-id-type="pmid">30119911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vacante</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borz&#x000ec;</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Basile</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Biondi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Biomarkers in colorectal cancer: Current clinical utility and future perspectives.</article-title>
            <source>World J Clin Cases</source>
            <year>2018</year>
            <month>Dec</month>
            <day>06</day>
            <volume>6</volume>
            <issue>15</issue>
            <fpage>869</fpage>
            <page-range>869-881</page-range>
            <pub-id pub-id-type="pmid">30568941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ballester</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rashtak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boardman</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Clinical and molecular features of young-onset colorectal cancer.</article-title>
            <source>World J Gastroenterol</source>
            <year>2016</year>
            <month>Feb</month>
            <day>07</day>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>1736</fpage>
            <page-range>1736-44</page-range>
            <pub-id pub-id-type="pmid">26855533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Identification a nonsense mutation of <italic>APC</italic> gene in Chinese patients with familial adenomatous polyposis.</article-title>
            <source>Exp Ther Med</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>1495</fpage>
            <page-range>1495-1499</page-range>
            <pub-id pub-id-type="pmid">28413499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De' Angelis</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Bottarelli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Azzoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De' Angelis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Leandro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Di Mario</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gaiani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Negri</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Microsatellite instability in colorectal cancer.</article-title>
            <source>Acta Biomed</source>
            <year>2018</year>
            <month>Dec</month>
            <day>17</day>
            <volume>89</volume>
            <issue>9-S</issue>
            <fpage>97</fpage>
            <page-range>97-101</page-range>
            <pub-id pub-id-type="pmid">30561401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sepp&#x000e4;l&#x000e4;</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Holinski-Feder</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sala</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gareth Evans</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lindblom</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Macrae</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Blanco</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sijmons</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Jeffries</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vasen</surname>
                <given-names>HFA</given-names>
              </name>
              <name>
                <surname>Burn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nakken</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hovig</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>R&#x000f8;dland</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Tharmaratnam</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>de Vos Tot Nederveen Cappel</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wijnen</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Jenkins</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lalloo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sunde</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mints</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bertario</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pineda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Navarro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Renkonen-Sinisalo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Valentin</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Frayling</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Plazzer</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Pylvanainen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Genuardi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mecklin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Moeslein</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Capella</surname>
                <given-names>G</given-names>
              </name>
              <collab>Mallorca Group</collab>
            </person-group>
            <article-title>Cancer risk and survival in <italic>path_MMR</italic> carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database.</article-title>
            <source>Gut</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>67</volume>
            <issue>7</issue>
            <fpage>1306</fpage>
            <page-range>1306-1316</page-range>
            <pub-id pub-id-type="pmid">28754778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbaszadegan</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Moghbeli</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Genetic and molecular origins of colorectal Cancer among the Iranians: an update.</article-title>
            <source>Diagn Pathol</source>
            <year>2018</year>
            <month>Dec</month>
            <day>22</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>97</fpage>
            <pub-id pub-id-type="pmid">30579343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Markowitz</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Bertagnolli</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Molecular origins of cancer: Molecular basis of colorectal cancer.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Dec</month>
            <day>17</day>
            <volume>361</volume>
            <issue>25</issue>
            <fpage>2449</fpage>
            <page-range>2449-60</page-range>
            <pub-id pub-id-type="pmid">20018966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pellat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Netter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Perkins</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Coulet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Parc</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Svrcek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Duval</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Andr&#x000e9;</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>[Lynch syndrome: What is new?].</article-title>
            <source>Bull Cancer</source>
            <year>2019</year>
            <season>Jul-Aug</season>
            <volume>106</volume>
            <issue>7-8</issue>
            <fpage>647</fpage>
            <page-range>647-655</page-range>
            <pub-id pub-id-type="pmid">30527816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rodgers</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Shannon</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mattia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lauwers</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Iafrate</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Hartford</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Oliva</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.</article-title>
            <source>Cancer</source>
            <year>2018</year>
            <month>Aug</month>
            <day>01</day>
            <volume>124</volume>
            <issue>15</issue>
            <fpage>3145</fpage>
            <page-range>3145-3153</page-range>
            <pub-id pub-id-type="pmid">29750335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morin</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Colorectal cancer: the APC-lncRNA link.</article-title>
            <source>J Clin Invest</source>
            <year>2019</year>
            <month>Feb</month>
            <day>01</day>
            <volume>129</volume>
            <issue>2</issue>
            <fpage>503</fpage>
            <page-range>503-505</page-range>
            <pub-id pub-id-type="pmid">30640173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Clinical and molecular characteristics of a child with familial adenomatous polyposis].</article-title>
            <source>Zhonghua Er Ke Za Zhi</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>205</fpage>
            <page-range>205-8</page-range>
            <pub-id pub-id-type="pmid">26957067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Vo</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Truong</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Do</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Phan</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>HN</given-names>
              </name>
            </person-group>
            <article-title>Detection of a heterozygous germline APC mutation in a three-generation family with familial adenomatous polyposis using targeted massive parallel sequencing in Vietnam.</article-title>
            <source>BMC Med Genet</source>
            <year>2018</year>
            <month>Oct</month>
            <day>19</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>188</fpage>
            <pub-id pub-id-type="pmid">30340471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sample</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Samadder</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Pappas</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Boucher</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Samowitz</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Westover</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nathan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kanth</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Burt</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Neklason</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.</article-title>
            <source>BMC Gastroenterol</source>
            <year>2018</year>
            <month>Jul</month>
            <day>16</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>115</fpage>
            <pub-id pub-id-type="pmid">30012100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kallenberg</surname>
                <given-names>FGJ</given-names>
              </name>
              <name>
                <surname>Bastiaansen</surname>
                <given-names>BAJ</given-names>
              </name>
              <name>
                <surname>Nio</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Soeters</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Boermeester</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Aalfs</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Bossuyt</surname>
                <given-names>PMM</given-names>
              </name>
              <name>
                <surname>Dekker</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Adrenal Lesions in Patients With (Attenuated) Familial Adenomatous Polyposis and MUTYH-Associated Polyposis.</article-title>
            <source>Dis Colon Rectum</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>60</volume>
            <issue>10</issue>
            <fpage>1057</fpage>
            <page-range>1057-1064</page-range>
            <pub-id pub-id-type="pmid">28891849</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hatfield</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Warden</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Parfrey</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Impact of colonoscopic screening in Familial Colorectal Cancer Type X.</article-title>
            <source>Mol Genet Genomic Med</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>1021</fpage>
            <page-range>1021-1030</page-range>
            <pub-id pub-id-type="pmid">30300963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kroijer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kobaek-Larsen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Qvist</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Knudsen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Baatrup</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Colon capsule endoscopy for colonic surveillance.</article-title>
            <source>Colorectal Dis</source>
            <year>2019</year>
            <month>May</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>532</fpage>
            <page-range>532-537</page-range>
            <pub-id pub-id-type="pmid">30637886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Causada-Calo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Santino</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Dominguez-Valentin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferro</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Sammartino</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kalfayan</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Verzura</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Pi&#x000f1;ero</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Cajal</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Pavicic</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Vaccaro</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Universal determination of microsatellite instability using BAT26 as a single marker in an Argentine colorectal cancer cohort.</article-title>
            <source>Fam Cancer</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>395</fpage>
            <page-range>395-402</page-range>
            <pub-id pub-id-type="pmid">29128931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moufid</surname>
                <given-names>FZ</given-names>
              </name>
              <name>
                <surname>Bouguenouch</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>El Bouchikhi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Chbani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Iraqui Houssaini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sekal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Belhassan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bennani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ouldim</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence.</article-title>
            <source>Genet Test Mol Biomarkers</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>22</volume>
            <issue>8</issue>
            <fpage>492</fpage>
            <page-range>492-497</page-range>
            <pub-id pub-id-type="pmid">30044143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arakawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hata</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kawai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nishikawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shuno</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kaneko</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hiyoshi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Emoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Murono</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nozawa</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Predictors for High Microsatellite Instability in Patients with Colorectal Cancer Fulfilling the Revised Bethesda Guidelines.</article-title>
            <source>Anticancer Res</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>8</issue>
            <fpage>4871</fpage>
            <page-range>4871-4876</page-range>
            <pub-id pub-id-type="pmid">30061262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klan&#x0010d;ar</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Blatnik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>&#x00160;etraj&#x0010d;i&#x0010d; Drago&#x00161;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Vogri&#x0010d;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Stegel</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Blatnik</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Drev</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gazi&#x0010d;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Krajc</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Novakovi&#x00107;</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A Novel Germline <italic>MLH1</italic> In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue.</article-title>
            <source>Genes (Basel)</source>
            <year>2020</year>
            <month>Mar</month>
            <day>18</day>
            <volume>11</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">32197529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cox</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Saeed Bamashmos</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Foo</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yedururi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Lynch Syndrome: Genomics Update and Imaging Review.</article-title>
            <source>Radiographics</source>
            <year>2018</year>
            <season>Mar-Apr</season>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>483</fpage>
            <page-range>483-499</page-range>
            <pub-id pub-id-type="pmid">29528821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walkowska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kallemose</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>J&#x000f6;nsson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>J&#x000f6;nsson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Svane</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Langkilde</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nilbert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Therkildsen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Immunoprofiles of colorectal cancer from Lynch syndrome.</article-title>
            <source>Oncoimmunology</source>
            <year>2019</year>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>e1515612</fpage>
            <pub-id pub-id-type="pmid">30546958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGee</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>AlGhareeb</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Babak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Biagi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Booth</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boss&#x000e9;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Champion</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Colwell</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Finn</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Goel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Harb</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hyde</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jeyakumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jonker</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kanagaratnam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kavan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>MacMillan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Muinuddin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ramjeesingh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Raza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rorke</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Servidio-Italiano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Siddiqui</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Simms</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smithson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Snow</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>St-Hilaire</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stuckless</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tate</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tehfe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thirlwell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsvetkova</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Valdes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vickers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Virik</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Welch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marginean</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Asmis</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Eastern Canadian Colorectal Cancer Consensus Conference 2017.</article-title>
            <source>Curr Oncol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>262</fpage>
            <page-range>262-274</page-range>
            <pub-id pub-id-type="pmid">30111967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mocellin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baretta</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Roqu&#x000e9; I Figuls</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sol&#x000e0;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Martin-Richard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hallum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bonfill Cosp</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Second-line systemic therapy for metastatic colorectal cancer.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Jan</month>
            <day>27</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>CD006875</fpage>
            <pub-id pub-id-type="pmid">28128439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Snyder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bottiglieri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Almhanna</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Impact of Primary Tumor Location on First-line Bevacizumab or Cetuximab in Metastatic Colorectal Cancer.</article-title>
            <source>Rev Recent Clin Trials</source>
            <year>2018</year>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-149</page-range>
            <pub-id pub-id-type="pmid">29595113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Qian</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>97</volume>
            <issue>10</issue>
            <fpage>e0097</fpage>
            <pub-id pub-id-type="pmid">29517682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Meng</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Qiu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Total neoadjuvant treatment (CAPOX plus radiotherapy) for patients with locally advanced rectal cancer with high risk factors: A phase 2 trial.</article-title>
            <source>Radiother Oncol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>129</volume>
            <issue>2</issue>
            <fpage>300</fpage>
            <page-range>300-305</page-range>
            <pub-id pub-id-type="pmid">30381141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>YX</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Outcomes after hypofractionated stereotactic radiotherapy for colorectal cancer oligometastases.</article-title>
            <source>J Surg Oncol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>119</volume>
            <issue>4</issue>
            <fpage>532</fpage>
            <page-range>532-538</page-range>
            <pub-id pub-id-type="pmid">30609038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maeda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cannom</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Beart</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Etzioni</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Decision model of segmental compared with total abdominal colectomy for colon cancer in hereditary nonpolyposis colorectal cancer.</article-title>
            <source>J Clin Oncol</source>
            <year>2010</year>
            <month>Mar</month>
            <day>01</day>
            <volume>28</volume>
            <issue>7</issue>
            <fpage>1175</fpage>
            <page-range>1175-80</page-range>
            <pub-id pub-id-type="pmid">20124166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Efficacy, functional outcome and post-operative complications of total abdominal colectomy with ileorectal anastomosis vs. segmental colectomy in hereditary non-polyposis colorectal cancer.</article-title>
            <source>Exp Ther Med</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>1603</fpage>
            <page-range>1603-1612</page-range>
            <pub-id pub-id-type="pmid">30186378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schneider</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>B&#x000fc;ttner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Reinacher-Schick</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tannapfel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>F&#x000fc;rst</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>R&#x000fc;schoff</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jakobeit</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Royer-Pokora</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>M&#x000f6;slein</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>[Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].</article-title>
            <source>Zentralbl Chir</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>140</volume>
            <issue>6</issue>
            <fpage>591</fpage>
            <page-range>591-9</page-range>
            <pub-id pub-id-type="pmid">25372301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herzig</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Buie</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Weiser</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>YN</given-names>
              </name>
              <name>
                <surname>Rafferty</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Feingold</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Clinical Practice Guidelines for the Surgical Treatment of Patients With Lynch Syndrome.</article-title>
            <source>Dis Colon Rectum</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>60</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-143</page-range>
            <pub-id pub-id-type="pmid">28059909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalady</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Church</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Prophylactic colectomy: Rationale, indications, and approach.</article-title>
            <source>J Surg Oncol</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>111</volume>
            <issue>1</issue>
            <fpage>112</fpage>
            <page-range>112-7</page-range>
            <pub-id pub-id-type="pmid">25418116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamadera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ueno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Konishi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ishida</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hinoi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kanemitsu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tomita</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ishida</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sugihara</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Current status of prophylactic surgical treatment for familial adenomatous polyposis in Japan.</article-title>
            <source>Surg Today</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>47</volume>
            <issue>6</issue>
            <fpage>690</fpage>
            <page-range>690-696</page-range>
            <pub-id pub-id-type="pmid">27770209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kennelly</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Gryfe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Familial colorectal cancer: Patient assessment, surveillance and surgical management.</article-title>
            <source>Eur J Surg Oncol</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>294</fpage>
            <page-range>294-302</page-range>
            <pub-id pub-id-type="pmid">27546013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goral</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Highland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lovell</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>Head and neck presentation of Gardner Syndrome: A pediatric case series.</article-title>
            <source>Int J Pediatr Otorhinolaryngol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>110</volume>
            <fpage>31</fpage>
            <page-range>31-33</page-range>
            <pub-id pub-id-type="pmid">29859582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r67">
          <label>67</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gay</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Troxell</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <chapter-title>Muir-Torre Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>3</day>
            <pub-id pub-id-type="pmid">30020643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Velter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Caussade</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fricker</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Cribier</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>[Muir-Torre syndrome and Turcot syndrome].</article-title>
            <source>Ann Dermatol Venereol</source>
            <year>2017</year>
            <season>Aug-Sep</season>
            <volume>144</volume>
            <issue>8-9</issue>
            <fpage>525</fpage>
            <page-range>525-529</page-range>
            <pub-id pub-id-type="pmid">28256262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r69">
          <label>69</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Khattab</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Monga</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <chapter-title>Turcot Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">30521203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r70">
          <label>70</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Larsen Haidle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>MacFarland</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Howe</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <chapter-title>Juvenile Polyposis Syndrome</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2003</year>
            <month>5</month>
            <day>13</day>
            <pub-id pub-id-type="pmid">20301642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonzalez</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Adsay</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Shroff</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Feely</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Drage</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Lewin</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Swanson</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Yantiss</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Ba&#x0011f;ci</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Krasinskas</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Massive gastric juvenile-type polyposis: a clinicopathological analysis of 22 cases.</article-title>
            <source>Histopathology</source>
            <year>2017</year>
            <month>May</month>
            <volume>70</volume>
            <issue>6</issue>
            <fpage>918</fpage>
            <page-range>918-928</page-range>
            <pub-id pub-id-type="pmid">27991685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmed</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alsaleem</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Nonfamilial Juvenile Polyposis Syndrome with Exon 5 Novel Mutation in SMAD 4 Gene.</article-title>
            <source>Case Rep Pediatr</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>5321860</fpage>
            <pub-id pub-id-type="pmid">28428902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jia</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Sheng</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Diagnosis and treatment for 46 cases of Peutz-Jeghers syndrome].</article-title>
            <source>Zhong Nan Da Xue Xue Bao Yi Xue Ban</source>
            <year>2018</year>
            <month>Dec</month>
            <day>28</day>
            <volume>43</volume>
            <issue>12</issue>
            <fpage>1323</fpage>
            <page-range>1323-1327</page-range>
            <pub-id pub-id-type="pmid">30643048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r74">
          <label>74</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Wu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krishnamurthy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Peutz-Jeghers Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">30570978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khanna</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Khanna</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Peutz-Jeghers syndrome: need for early screening.</article-title>
            <source>BMJ Case Rep</source>
            <year>2018</year>
            <month>Dec</month>
            <day>13</day>
            <volume>11</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30567229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sloot</surname>
                <given-names>YJE</given-names>
              </name>
              <name>
                <surname>Rabold</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Netea</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Smit</surname>
                <given-names>JWA</given-names>
              </name>
              <name>
                <surname>Hoogerbrugge</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Netea-Maier</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome.</article-title>
            <source>Oncogene</source>
            <year>2019</year>
            <month>May</month>
            <volume>38</volume>
            <issue>19</issue>
            <fpage>3743</fpage>
            <page-range>3743-3755</page-range>
            <pub-id pub-id-type="pmid">30670777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yehia</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ngeow</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eng</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>PTEN-opathies: from biological insights to evidence-based precision medicine.</article-title>
            <source>J Clin Invest</source>
            <year>2019</year>
            <month>Feb</month>
            <day>01</day>
            <volume>129</volume>
            <issue>2</issue>
            <fpage>452</fpage>
            <page-range>452-464</page-range>
            <pub-id pub-id-type="pmid">30614812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harada</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Umeno</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Esaki</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Gastrointestinal: Multiple venous malformations and polyps of the small intestine in Cowden syndrome.</article-title>
            <source>J Gastroenterol Hepatol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>11</issue>
            <fpage>1819</fpage>
            <pub-id pub-id-type="pmid">29952025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Won</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Na</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Whang</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers.</article-title>
            <source>Cancer Res Treat</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>402</fpage>
            <page-range>402-407</page-range>
            <pub-id pub-id-type="pmid">29510612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bhattacharjee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bhansali</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Protean manifestations of Proteus syndrome.</article-title>
            <source>Postgrad Med J</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>94</volume>
            <issue>1113</issue>
            <fpage>416</fpage>
            <pub-id pub-id-type="pmid">29626058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caux</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Plauchu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chibon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Faivre</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fain</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Vabres</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bonnet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Selma</surname>
                <given-names>ZB</given-names>
              </name>
              <name>
                <surname>Laroche</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>G&#x000e9;rard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Longy</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity.</article-title>
            <source>Eur J Hum Genet</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>15</volume>
            <issue>7</issue>
            <fpage>767</fpage>
            <page-range>767-73</page-range>
            <pub-id pub-id-type="pmid">17392703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tian</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>A Novel Mutation in <italic>MYH</italic> Gene Associated with Aggressive Colorectal Cancer in a Child: A Case Report and Review of Literature.</article-title>
            <source>Onco Targets Ther</source>
            <year>2020</year>
            <volume>13</volume>
            <fpage>8557</fpage>
            <page-range>8557-8565</page-range>
            <pub-id pub-id-type="pmid">32904697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Ihn</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Ju</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Impact of Family History on Prognosis of Patients with Sporadic Colorectal Cancer.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>1118</fpage>
            <page-range>1118-1126</page-range>
            <pub-id pub-id-type="pmid">30684157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thong</surname>
                <given-names>MSY</given-names>
              </name>
              <name>
                <surname>Koch-Gallenkamp</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bertram</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Eberle</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Holleczek</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Waldeyer-Sauerland</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Waldmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zeissig</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Brenner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Arndt</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls - a population-based study.</article-title>
            <source>Acta Oncol</source>
            <year>2019</year>
            <month>May</month>
            <volume>58</volume>
            <issue>5</issue>
            <fpage>801</fpage>
            <page-range>801-810</page-range>
            <pub-id pub-id-type="pmid">30736716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vanaclocha-Espi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ib&#x000e1;&#x000f1;ez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Molina-Barcel&#x000f3;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Valverde-Roig</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nolasco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de la Vega</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de la Lastra-Bosch</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Oceja</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Espin&#x000e0;s</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Font</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Riquelme</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Arana-Arri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Portillo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Salas</surname>
                <given-names>D</given-names>
              </name>
              <collab>CRIBEA Group</collab>
            </person-group>
            <article-title>Risk factors for severe complications of colonoscopy in screening programs.</article-title>
            <source>Prev Med</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>118</volume>
            <fpage>304</fpage>
            <page-range>304-308</page-range>
            <pub-id pub-id-type="pmid">30414944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carlomagno</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Santangelo</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Amato</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Calogero</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saracco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cremone</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Miranda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dodaro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Renda</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Total colectomy for cancer: analysis of factors linked to patients' age.</article-title>
            <source>Int J Surg</source>
            <year>2014</year>
            <volume>12 Suppl 2</volume>
            <fpage>S135</fpage>
            <page-range>S135-S139</page-range>
            <pub-id pub-id-type="pmid">25181631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Ahnen</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Colorectal Cancer in the Young.</article-title>
            <source>Curr Gastroenterol Rep</source>
            <year>2018</year>
            <month>Mar</month>
            <day>28</day>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>15</fpage>
            <pub-id pub-id-type="pmid">29616330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nimptsch</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Is Timing Important? The Role of Diet and Lifestyle during Early Life on Colorectal Neoplasia.</article-title>
            <source>Curr Colorectal Cancer Rep</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-11</page-range>
            <pub-id pub-id-type="pmid">30140177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LaDuca</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>McFarland</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gutierrez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yussuf</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pepper</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Reineke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cain</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Blanco</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Horton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dolinsky</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Quality of Clinician-Reported Cancer History When Ordering Genetic Testing.</article-title>
            <source>JCO Clin Cancer Inform</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>2</volume>
            <fpage>1</fpage>
            <page-range>1-11</page-range>
            <pub-id pub-id-type="pmid">30652589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mauri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sartore-Bianchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Marsoni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bardelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siena</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Early-onset colorectal cancer in young individuals.</article-title>
            <source>Mol Oncol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>109</fpage>
            <page-range>109-131</page-range>
            <pub-id pub-id-type="pmid">30520562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinberg</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Colon Cancer in Young Adults: Trends and Their Implications.</article-title>
            <source>Curr Oncol Rep</source>
            <year>2019</year>
            <month>Jan</month>
            <day>18</day>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <pub-id pub-id-type="pmid">30659375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yurgelun</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Hampel</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention.</article-title>
            <source>Am Soc Clin Oncol Educ Book</source>
            <year>2018</year>
            <month>May</month>
            <day>23</day>
            <volume>38</volume>
            <fpage>101</fpage>
            <page-range>101-109</page-range>
            <pub-id pub-id-type="pmid">30231390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biller</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Syngal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yurgelun</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Recent advances in Lynch syndrome.</article-title>
            <source>Fam Cancer</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>211</fpage>
            <page-range>211-219</page-range>
            <pub-id pub-id-type="pmid">30627969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barrow</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lalloo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome.</article-title>
            <source>Br J Surg</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>100</volume>
            <issue>13</issue>
            <fpage>1719</fpage>
            <page-range>1719-31</page-range>
            <pub-id pub-id-type="pmid">24227356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coelho</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jones-Hughes</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Snowsill</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Briscoe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Huxley</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Frayling</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Hyde</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>A systematic review of test accuracy studies evaluating molecular micro-satellite instability testing for the detection of individuals with lynch syndrome.</article-title>
            <source>BMC Cancer</source>
            <year>2017</year>
            <month>Dec</month>
            <day>08</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>836</fpage>
            <pub-id pub-id-type="pmid">29221446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis.</article-title>
            <source>Am J Epidemiol</source>
            <year>2013</year>
            <month>Jun</month>
            <day>01</day>
            <volume>177</volume>
            <issue>11</issue>
            <fpage>1169</fpage>
            <page-range>1169-79</page-range>
            <pub-id pub-id-type="pmid">23576677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liang</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>HX</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>SX</given-names>
              </name>
            </person-group>
            <article-title>APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review.</article-title>
            <source>Oncotarget</source>
            <year>2017</year>
            <month>Jul</month>
            <day>11</day>
            <volume>8</volume>
            <issue>28</issue>
            <fpage>46468</fpage>
            <page-range>46468-46479</page-range>
            <pub-id pub-id-type="pmid">28515349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wakeman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Keenan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eteuati</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hollington</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Eglinton</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Frizelle</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Chemoprevention of colorectal neoplasia.</article-title>
            <source>ANZ J Surg</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>87</volume>
            <issue>12</issue>
            <fpage>E228</fpage>
            <page-range>E228-E232</page-range>
            <pub-id pub-id-type="pmid">26686322</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dicks</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pullman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kao</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>MacMillan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Simmonds</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Etchegary</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Universal tumor screening for Lynch syndrome: perspectives of Canadian pathologists and genetic counselors.</article-title>
            <source>J Community Genet</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>335</fpage>
            <page-range>335-344</page-range>
            <pub-id pub-id-type="pmid">30465127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaitanidis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spathakis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsalikidis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alevizakos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsaroucha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pitiakoudis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for cardiovascular mortality in patients with colorectal cancer: a population-based study.</article-title>
            <source>Int J Clin Oncol</source>
            <year>2019</year>
            <month>May</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>501</fpage>
            <page-range>501-507</page-range>
            <pub-id pub-id-type="pmid">30604158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Combination adjuvant chemotherapy with targeted drugs for treatment of colorectal cancer: A network meta-analysis.</article-title>
            <source>J Cell Biochem</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>119</volume>
            <issue>2</issue>
            <fpage>1521</fpage>
            <page-range>1521-1537</page-range>
            <pub-id pub-id-type="pmid">28771807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>da Silva</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>de Araujo</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>EMEA</given-names>
              </name>
              <name>
                <surname>Dos Santos</surname>
                <given-names>JBR</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>MRRD</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>PHRF</given-names>
              </name>
              <name>
                <surname>de Assis Acurcio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Godman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kurdi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cherchiglia</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Andrade</surname>
                <given-names>EIG</given-names>
              </name>
            </person-group>
            <article-title>Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.</article-title>
            <source>BioDrugs</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>585</fpage>
            <page-range>585-606</page-range>
            <pub-id pub-id-type="pmid">30499082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jayedi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Emadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shab-Bidar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Dietary Inflammatory Index and Site-Specific Cancer Risk: A Systematic Review and Dose-Response&#x02009; Meta-Analysis.</article-title>
            <source>Adv Nutr</source>
            <year>2018</year>
            <month>Jul</month>
            <day>01</day>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>388</fpage>
            <page-range>388-403</page-range>
            <pub-id pub-id-type="pmid">30032224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kong</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Dietary fiber intake and risks of proximal and distal colon cancers: A meta-analysis.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>97</volume>
            <issue>36</issue>
            <fpage>e11678</fpage>
            <pub-id pub-id-type="pmid">30200062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gianfredi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Salvatori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Villarini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moretti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nucci</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Realdon</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Is dietary fibre truly protective against colon cancer? A systematic review and meta-analysis.</article-title>
            <source>Int J Food Sci Nutr</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>69</volume>
            <issue>8</issue>
            <fpage>904</fpage>
            <page-range>904-915</page-range>
            <pub-id pub-id-type="pmid">29516760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>CHA</given-names>
              </name>
              <name>
                <surname>Kong</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Ismail</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Riedel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Heriot</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Systematic Review and Meta-analysis of Objective Assessment of Physical Fitness in Patients Undergoing Colorectal Cancer Surgery.</article-title>
            <source>Dis Colon Rectum</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>400</fpage>
            <page-range>400-409</page-range>
            <pub-id pub-id-type="pmid">29377872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22813.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piraux</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Caty</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Reychler</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Effects of preoperative combined aerobic and resistance exercise training in cancer patients undergoing tumour resection surgery: A systematic review of randomised trials.</article-title>
            <source>Surg Oncol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>584</fpage>
            <page-range>584-594</page-range>
            <pub-id pub-id-type="pmid">30217322</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
